5:57 PM
 | 
Jun 11, 2010
 |  BC Extra  |  Company News

FDA extends Acthar review

FDA extended the PDUFA date for an sNDA from Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) for H.P. Acthar Gel by three months to Sept. 11 from...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >